It seems we can’t find what you’re looking for. Perhaps searching can help.
1843 - 1988
London Health Sciences Centre – A Randomized Phase II Trial Assessing Trimodality Therapy With/Out Adjuvant Durvalumab to Treat Patients With Muscle-Invasive Bladder Cancer